LADONNA MAXWELL: Open Payments
NPI 1417037292 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,062 in 35 payments from 8 companies in 2025. Trend: 2023 $393 · 2024 $222 · 2025 $1,062
Food & beverage: $1,062
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $252 |
| ABBVIE INC. | 18 | $212 |
| Janssen Pharmaceuticals, Inc | 3 | $157 |
| Novo Nordisk Inc | 6 | $152 |
| Organogenesis Inc. | 1 | $130 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $82 |
| Amgen Inc. | 2 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $30 |
Products named: INVEGA, AFFINITY, FARXIGA, Ozempic, AIRSUPRA, UBRELVY, VRAYLAR, CAPLYTA.
Industry payments across MT — which companies pay providers there.
